GSK vs MEC · P/E 13, $103.31B cap vs P/E 15, rev $307.8M
GlaxoSmithKline PLC ADR (GSK) versus Mayville Engineering Co Inc (MEC) — a side-by-side from cached financials, not a winner call.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
Mayville Engineering Co Inc (MEC) is a metal fabrication company listed on US.
GSK does not have a complete income-statement cache yet.
Latest reported MEC revenue for 2026-06-30 was $307.8M. Net income was -$10.3M. MEC currently screens at market cap $337.6M and trailing P/E 15.0.
GSK currently screens at market cap $103.31B and trailing P/E 13.5. MEC currently screens at market cap $337.6M and trailing P/E 15.0.
Not investment advice. Open the GSK and MEC stock pages for the full models.
Not investment advice.